Received Sep 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y017512 | — |
No additional AE; administering PROQUAD after experiencing a temperature excursion; This spontaneous report was received from a Physician Assistant (reported as medical assistant) and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with an improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), administered for prophylaxis (lot number Y017512 has been verified to be valid for Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live [PROQUAD], expiration date 19-APR-2026; dose, formulation, route of administration, anatomical site of injection and dose number were not provided), which was reconstituted with sterile diluent (Hollister-Stier STERILE DILUENT) (expiration date, and lot number were not reported). The vaccine was administered after a temperature excursion (TE) at -13.4 degree Celsius (C) for 9 hours and 32 minutes, with a previous TE at -12.9 degree C for 2 hours and 22 minutes (Product storage error). No additional adverse event was reported for the patient. This is one of several reports received from the same reporter.
Sterile diluent